Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolism of Clopidogrel”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Post-approval studies (Phase 4)Study completedNCT00296803
What this trial is testing

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Who this might be right for
Metabolic Syndrome x
Sanofi 216
Not applicableStudy completedNCT01276275
What this trial is testing

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Who this might be right for
Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout
AstraZeneca 7,200
Large-scale testing (Phase 3)UnknownNCT02048228
What this trial is testing

Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS

Who this might be right for
CLOPIDOGREL, POOR METABOLISM of (Disorder)
Chinese PLA General Hospital 200
Post-approval studies (Phase 4)Study completedNCT02663713
What this trial is testing

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction

Who this might be right for
Myocardial InfarctionDiabetes MellitusRenal Disease+1 more
University of Patras 20
Not applicableUnknownNCT04642209
What this trial is testing

Aggregometry in Elderlies With Hip Fracture and Receiving Clopidogrel

Who this might be right for
Hip FracturesClopidogrel, Poor Metabolism ofAnesthesia
University Magna Graecia 9
Post-approval studies (Phase 4)Study completedNCT02748330
What this trial is testing

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)WithdrawnNCT04069234
What this trial is testing

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.

Who this might be right for
Diabetes MellitusMicrovascular Coronary Artery Disease
Region Skane
Post-approval studies (Phase 4)Study completedNCT04484259
What this trial is testing

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
University of Florida 105
Post-approval studies (Phase 4)Study completedNCT03329261
What this trial is testing

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Who this might be right for
Diabetes Mellitus, Type 2NSTEMI - Non-ST Segment Elevation MICoronary Angioplasty
Laboratoires Teriak 167
Post-approval studies (Phase 4)UnknownNCT04088513
What this trial is testing

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

Who this might be right for
G6PD DeficiencyStroke
First Affiliated Hospital, Sun Yat-Sen University 440
Post-approval studies (Phase 4)Study completedNCT03437044
What this trial is testing

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
University of Florida 40
Post-approval studies (Phase 4)UnknownNCT01643031
What this trial is testing

Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel

Who this might be right for
Diabetes MellitusCoronary Disease
Rabin Medical Center 500
Post-approval studies (Phase 4)Study completedNCT00728156
What this trial is testing

Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)

Who this might be right for
Type 2 Diabetes MellitusCoronary Artery Disease
Newcastle-upon-Tyne Hospitals NHS Trust 90
Post-approval studies (Phase 4)Study completedNCT03774394
What this trial is testing

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Who this might be right for
Chronic Kidney Disease (CKD)Type 2 Diabetes Mellitus (T2DM)Coronary Artery Disease (CAD)
University of Florida 61
Post-approval studies (Phase 4)UnknownNCT02411903
What this trial is testing

The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

Who this might be right for
Cerebral InfarctionClopidogrel,Poor Metabolism of (Disorder)
The Third Affiliated Hospital of Guangzhou Medical University 160
Testing effectiveness (Phase 2)Study completedNCT00642174
What this trial is testing

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Who this might be right for
Diabetes MellitusCoronary Artery Disease
Eli Lilly and Company 35
Large-scale testing (Phase 3)Ended earlyNCT04007055
What this trial is testing

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Who this might be right for
Peripheral Artery DiseaseClopidogrel, Poor Metabolism ofPeripheral Vascular Disease+2 more
Marissa Jarosinski 31
Not applicableStudy completedNCT01991093
What this trial is testing

Multiple Electrode Aggregometry & Clopidogrel Resistance

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Coronary Artery Disease (CAD)Myocardial Infraction
Elpen Pharmaceutical Co. Inc. 280
Post-approval studies (Phase 4)Study completedNCT02742987
What this trial is testing

Clopidogrel Versus Ticagrelor in Type-2 Diabetes

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus
Campus Bio-Medico University 42
Post-approval studies (Phase 4)UnknownNCT02457130
What this trial is testing

Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus. Type 2
Spanish Society of Cardiology 30
Next Page